Hypoxic and normoxic-human Wharton’s Jelly mesenchymal stem cell-free lysate for anticancer therapies

Wahyu Widowati, Diana Krisanti Jasaputra, Hanna Sari Widya Kusuma, Rizal Rizal, Dian Ratih Laksmitawati, Dwi Surya Artie, Ika Adhani Sholihah, Dewani Tediana Yusepany, Riyani Lestari, Anisa Siwianti Handayani, Seila Arumwardana, Harry Murti, Indra Bachtiar, Mawar Subangkit

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Cancer can be defined as a disease in which a group of uncontrolled cells growth by ignoring the rules of normal cell division. Mesenchymal Stem Cells (MSCs) are one of the promising cell-based therapies for anticancer therapies. Preceding research had disclosed that conditioned medium from hypoxic-treated human Wharton’s jelly mesenchymal stem cells (hWJMSCs-hypoCM) and normoxictreated hWJMSCs (hWJMSCs-norCM) can inhibit the proliferation of various cancer cell lines and have no cytotoxic effect on normal cells. The present study, hence, measured the effect of a human Wharton’s jelly stem cells cell-free lysate (hWJMSCs-CL), cultured with hypoxic condition (hWJMSCs-hypoCL), and normoxic condition (hWJMSCs-norCL) towards several cancer cell lines including ovarian (SKOV3), cervical (HeLa), tongue squamosa (HSC3), and liver (HepG2) proliferation. Human mesenchymal stem cells (hMSCs), human fibroblast cells, and mouse fibroblast cells (NIH3T3) were used as control. Both hWJMSCs-CL grown in hypoxic and normoxic conditions could inhibit the proliferation of various cancer cell lines with median inhibitory concentration (IC50) 21.09-95.92 μg/mL and could cause low inhibition of the normal cells with IC50 409.19-799.74 μg/mL. The hWJMSCshypoCL and hWJMSC-norCL could inhibit various cancer and were not harmful to normal cells.

Original languageEnglish
Article number9270
JournalWalailak Journal of Science and Technology
Volume18
Issue number9
DOIs
Publication statusPublished - 1 May 2021

Keywords

  • Anticancer
  • Cell-free lysate
  • Hypoxia
  • Mesenchymal stem cells
  • Wharton’s Jelly

Fingerprint

Dive into the research topics of 'Hypoxic and normoxic-human Wharton’s Jelly mesenchymal stem cell-free lysate for anticancer therapies'. Together they form a unique fingerprint.

Cite this